TY - JOUR
T1 - Autophagy induction impairs migration and invasion by reversing EMT in glioblastoma cells
AU - Catalano, Myriam
AU - D'Alessandro, Giuseppina
AU - Lepore, Francesca
AU - Corazzari, Marco
AU - Caldarola, Sara
AU - Valacca, Cristina
AU - Faienza, Fiorella
AU - Esposito, Vincenzo
AU - Limatola, Cristina
AU - Cecconi, Francesco
AU - Di Bartolomeo, Sabrina
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Cell migration and invasion are highly regulated processes involved in both physiological and pathological conditions. Here we show that autophagy modulation regulates the migration and invasion capabilities of glioblastoma (GBM) cells. We observed that during autophagy occurrence, obtained by nutrient deprivation or by pharmacological inhibition of the mTOR complexes, GBM migration and chemokine-mediated invasion were both impaired. We also observed that SNAIL and SLUG, two master regulators of the epithelial-mesenchymal transition (EMT process), were down-regulated upon autophagy stimulation and, as a consequence, we found a transcriptional and translational up-regulation of N- and R-cadherins. Conversely, in BECLIN 1-silenced GBM cells, an increased migration capability and an up-regulation of SNAIL and SLUG was observed, with a resulting decrease in N- and R-cadherin mRNAs. ATG5 and ATG7 down-regulation also resulted in an increased migration and invasion of GBM cells combined to an up-regulation of the two EMT regulators. Finally, experiments performed in primary GBM cells from patients largely confirmed the results obtained in established cell cultures.Overall, our results indicate that autophagy modulation triggers a molecular switch from a mesenchymal phenotype to an epithelial-like one in GBM cellular models. Since the aggressiveness and lethality of GBM is defined by local invasion and resistance to chemotherapy, we believe that our evidence provides a further rationale for including autophagy/mTOR-based targets in the current therapeutical regimen of GBM patients.
AB - Cell migration and invasion are highly regulated processes involved in both physiological and pathological conditions. Here we show that autophagy modulation regulates the migration and invasion capabilities of glioblastoma (GBM) cells. We observed that during autophagy occurrence, obtained by nutrient deprivation or by pharmacological inhibition of the mTOR complexes, GBM migration and chemokine-mediated invasion were both impaired. We also observed that SNAIL and SLUG, two master regulators of the epithelial-mesenchymal transition (EMT process), were down-regulated upon autophagy stimulation and, as a consequence, we found a transcriptional and translational up-regulation of N- and R-cadherins. Conversely, in BECLIN 1-silenced GBM cells, an increased migration capability and an up-regulation of SNAIL and SLUG was observed, with a resulting decrease in N- and R-cadherin mRNAs. ATG5 and ATG7 down-regulation also resulted in an increased migration and invasion of GBM cells combined to an up-regulation of the two EMT regulators. Finally, experiments performed in primary GBM cells from patients largely confirmed the results obtained in established cell cultures.Overall, our results indicate that autophagy modulation triggers a molecular switch from a mesenchymal phenotype to an epithelial-like one in GBM cellular models. Since the aggressiveness and lethality of GBM is defined by local invasion and resistance to chemotherapy, we believe that our evidence provides a further rationale for including autophagy/mTOR-based targets in the current therapeutical regimen of GBM patients.
KW - Autophagy
KW - Cell migration
KW - EMT
KW - Glioma
UR - http://www.scopus.com/inward/record.url?scp=84942199396&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84942199396&partnerID=8YFLogxK
U2 - 10.1016/j.molonc.2015.04.016
DO - 10.1016/j.molonc.2015.04.016
M3 - Article
C2 - 26022108
AN - SCOPUS:84942199396
SN - 1574-7891
VL - 9
SP - 1612
EP - 1625
JO - Molecular Oncology
JF - Molecular Oncology
IS - 8
ER -